24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Stock
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:02
Rapyd raises $500M at $4.5B valuation to complete $610M PayU acquisition
15:31
Where will US markets find their bottom? A model points to a potential 11% drop
14:58
Matrix looks to Wall Street: $2.1 billion merger could pave way for Nasdaq listing
14:14
IAI reports record $6.1 billion in sales as global demand for weapons surges
More stories
Buzz
Most popular
Daily
Weekly
1
"Eventually, AI will surpass us in everything"—so what skills will still matter?
2
Cyber unicorn Pentera raises $60M at over $1B valuation as ARR approaches $100M
3
Sola Security aims to be the Wix of cyber with $30 million Seed round
4
QuamCore raises $9 million in Seed funding to build scalable 1 million qubit quantum computer
5
Cybereason secures $120 million investment amid leadership shakeup and abandoned merger
More news
Stock
3 stories about Stock
MediWound Loses Stock Purchase Agreement Case
14.11.17
|
Dror Reich
The burn and wound treatment company was ordered to follow through on previous agreement to buy shares of biotech company Polyheal
Allergan Planning Sale of its Teva Stock
01.11.17
|
Dror Reich and Lilach Baumer
For the third quarter of 2017, Allergan reported an operating loss of $4.02 billion, $1.3 billion of which is due to the depreciation of its Teva securities.
Teva Offloads Holdings in Australia’s Mesoblast
25.10.17
|
Dror Reich and Lilach Baumer
The stem-cell therapy company diluted Teva’s shares through a new offering in August
Previous Articles